histiocytosis
Information
- Disease name
- histiocytosis
- Disease ID
- DOID:3405
- Description
- "A lymphatic system disease that is characterized by an excessive number of histiocytes." [url:http\://en.wikipedia.org/wiki/Histiocytosis, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000068.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03127709 | Active, not recruiting | A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis | April 7, 2017 | April 2025 | |
| NCT00145626 | Completed | Phase 2 | HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies | May 2004 | July 2016 |
| NCT01225718 | Completed | Ceftriaxone in Non-neutropenic Fever | August 2010 | June 25, 2016 | |
| NCT01049854 | Completed | Phase 2 | CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant | September 2011 | August 2018 |
| NCT05803629 | Not yet recruiting | N/A | Characterizing Histiocytosis With 68Ga-FAPI PET/CT | May 1, 2023 | December 31, 2025 |
| NCT04943224 | Recruiting | Phase 2 | Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients | April 1, 2021 | June 23, 2026 |
| NCT05786924 | Recruiting | Phase 1 | A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers | April 18, 2023 | December 2026 |
| NCT05915208 | Recruiting | Histiocytic Disorder Follow-up Study | September 1, 2022 | December 2028 | |
| NCT04437381 | Recruiting | Molecular Targets for the Treatment of Histiocytosis | November 22, 2021 | May 2025 | |
| NCT04665674 | Recruiting | Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study | January 1, 2004 | December 31, 2035 | |
| NCT04943198 | Recruiting | Phase 2 | Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis | April 1, 2021 | June 23, 2026 |
| NCT04943211 | Recruiting | Phase 3 | Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging | April 1, 2021 | June 23, 2026 |
| NCT02012231 | Terminated | Phase 1 | Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. | February 2014 | June 2015 |
| NCT01050439 | Terminated | Phase 2 | Unrelated Donor Transplant for Malignant and Non-Malignant Disorders | November 2002 | April 2011 |
- Disase is a (Disease Ontology)
- DOID:75
- Cross Reference ID (Disease Ontology)
- MESH:D015614
- Cross Reference ID (Disease Ontology)
- NCI:C3106
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:60657004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0019618
- Exact Synonym (Disease Ontology)
- chronic Histiocytosis X
- Exact Synonym (Disease Ontology)
- Hand Schuller Christian disease
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100727
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015614